Skip to content

The effectiveness of Pivotal Response Treatment in children and adolescents with autism spectrum disorder: a randomized clinical trail

The effectiveness of Pivotal Response Treatment in children and adolescents with autism spectrum disorder: a randomized clinical trail - DAVINCI

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON44124
Enrollment
42
Registered
2016-03-01
Start date
2016-06-13
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ASD autism autism spectrum disorder

Interventions

Participants are randomized to one of the following conditions: 1) PRT condition: PRT on top of psycho-education 2) CAU condition: regular treatment of ASD (e.g. guidance of parents) on top of psych

Sponsors

Karakter Nijmegen
Lead Sponsor

Eligibility

Age
2 Years to 17 Years

Inclusion criteria

Inclusion criteria: • aged 9 - 15 years at inclusion in the study • Total Intelligence Quotient (TIQ) of >= 80 • clinically diagnosed with autism spectrum disorder (DSM-IV-TR and DSM-5) or social communication disorder (DSM-5) • at least one of the parents is able to understand and speak the Dutch language

Exclusion criteria

Exclusion criteria: -Systemic problems that limit the possibility to engage in an intensive treatment, focused on training both the child/adolescent and parents. -Presence of comorbid problems that require treatment first. -Problems with accepting child's diagnosis of ASD by child and/or parent -Severe parental psychopathology

Design outcomes

Primary

MeasureTime frame
1) Significant response on the SRS (continuous measure): generalized improvement in child's social and communicative skills

Secondary

MeasureTime frame
-Clinically significant increase at the CGI-I -Generalized social and communicative skills (SRS), percentage of clinical response -Child rearing pressur of parents (OBVL) -Parent-child interaction (PCI) -Change in ASD symptoms (ADOS-2) -Child adaptive behaviour (VABS) -Child internalizing and externalizing symptoms (CBCL)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)